Auxilium

News

This section provides essential news and information about Auxilium.

  • Press Releases - get the latest corporate information about Auxilium
  • Archive - see a complete listing of past press releases about Auxilium
  • Investor Kit - contact us to receive the latest investor relations information

For Investors - additional information and resources designed with investors in mind.

Recent News
DateTitle 
Dec 11, 2014Auxilium Announces Date for Special Meeting of Stockholders
CHESTERBROOK, Pa., Dec. 11, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that it has scheduled a special meeting of its stockholders for 8:30 a.m. ET on Tuesday, January 27, 2015 to approve matters relating to the previously announced proposed merger with Endo International plc. Auxilium stockholders of record at the close of business on December 23, 2014 will be mailed the proxy statement/prospectus in connection with the proposed merger and will be enti... 
Printer Friendly Version
Nov 20, 2014Auxilium Pharmaceuticals, Inc. Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting
Peyronie's Disease Data Presented Enable a Better Understanding of the Safety and Efficacy of XIAFLEX for Treatment of PD; First Data Presented on PD Treatment Impact on Female Partner Sexual Function CHESTERBROOK, Pa., Nov. 20, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced presentations of data from new studies, as well as new analyses of data from the Phase 2 and the pivotal Phase 3 IMPRESS (The Investigation for... 
Printer Friendly Version
Nov 20, 2014Auxilium Pharmaceuticals, Inc. Presents STENDRA Data At SMSNA Scientific Meeting
Erectile Dysfunction Data Presented in Two Moderated Posters; Findings Enable a Better Understanding of the STENDRA Clinical Profile and Provide Additional Data Regarding the Use of STENDRA as Early as Approximately 15 Minutes Before Sexual Activity CHESTERBROOK, Pa., Nov. 20, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data were presented regarding the use of STENDRA® (avanafil) tablets fo... 
Printer Friendly Version
Nov 19, 2014Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals
DUBLIN and CHESTERBROOK, Pa., Nov. 19, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act") in connection with Endo's proposed acquisition of Auxilium was terminated by the United States Federal Trade Commission on November 18, 2014. Endo now expects the deal to close in the first quarter of 2015, subject... 
Printer Friendly Version